Prot#WP-0512-003: A Phase 2a Open-Label Preliminary Safety, Efficacy, and Biomarker Study of WP-0512 in Patients with Amyotrophic Lateral Sclerosis (ALS)

Project: Research project

Project Details

StatusActive
Effective start/end date3/3/22 → 3/22/25

Funding

  • DP Clinical, Inc. (Prot#WP-0512-003)
  • Woolsey Pharmaceuticals, Inc. (Prot#WP-0512-003)